Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Narayan: “Polypill” for Cardiovascular Disease Prevention. (0.14 sec) 

“Polypill” for Cardiovascular Disease Prevention

- ypertasi.gr [PDF] 
KM Narayan - Clinical Diabetes, 2004 - Am Diabetes Assoc
Results. A polypill composed of a statin; three pressure-lowering drugs, each at
half of its standard dose; aspirin, 75 mg; and folic acid, 0.8 mg, was estimated
to potentially reduce IHD events by 88% (95% CI 84-91%) and stroke by 80% ...
Cited by 3 - Related articles - BL Direct - All 3 versions

Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular …


V Kumar, B Prasad, S Singh - Drug Discovery Today: Therapeutic Strategies, 2008 - Elsevier
Cardiovascular diseases (CVDs) are the foremost cause of mortality worldwide. It
is estimated that around 20 million people will die from CVDs by 2015.
Accordingly, there is a need to develop treatment strategies, which on ...
Cited by 2 - Related articles

[CITATION] Aspirin


K Florey - Profiles of Drug Substances, Excipients and Related …, 1979
Cited by 2 - Related articles

[CITATION] Atenolol


V Caplar, Z Mikotic-Mihun, H Hofman, J … - Analytical Profiles of Drug Substances, Academic …, 1992
Cited by 3 - Related articles

[CITATION] A study on the physical and chemical stability of anti-tuberculosis fixed-dose combination ( …


H Bhutani, TT Mariappan, S Singh - Int. J. Tuberc. Lung Dis, 2004
Cited by 3 - Related articles

[CITATION] The Indian Pharmacopoeial Commission


I Pharmacopoeia - India, 2007
Cited by 3 - Related articles

Multi-Constituent Cardiovascular Pills (MCCP)-Challenges and Promises of Population-Based …


MJ Jamieson, M Naghavi - Current pharmaceutical design, 2007 - ingentaconnect.com
1 Clinical Associate Professor of Medicine and Pharmacology, University of Texas
Health Science Center, San Antonio, Texas and Scientific Advisor to the
Association for Eradication of Heart Attack (AEHA) and
Cited by 4 - Related articles - BL Direct - All 4 versions

Compatibility of the antitumoral β-lapachone with different solid dosage forms excipients


MSS Cunha-Filho, R Martínez-Pacheco, M … - Journal of Pharmaceutical and Biomedical Analysis, 2007 - Elsevier
The objective of the present study was to evaluate the compatibility of the
β-lapachone (βLAP), an antitumoral drug in clinical phase, with pharmaceutical
excipients of common use including diluents, binders, disintegrants, ...
Cited by 6 - Related articles - All 2 versions

High-performance liquid chromatographic determination of simvastatin in medical drugs

- kfupm.edu.sa [PDF] 
ESM Abu-Nameh, RA Shawabkeh, A Ali - Journal of Analytical Chemistry, 2006 - Springer
Simvastatin belongs to the statin drug family, the members of which are used as
cholesterol-lowering agents for patients with hypercholesterolemia [1]. This
semisynthetic drug (Fig. 1) exhibits a very important hepatic first-pass ...
Cited by 5 - Related articles - BL Direct - All 7 versions

“Polypill” to fight cardiovascular disease: Authors' reply

- nih.gov [PDF] 
N Wald, M Law, J Morris, A Rudnicka, R … - BMJ: British Medical Journal, 2003 - pubmedcentral.nih.gov
Patients before populations Editor—Wald and Law's provocative paper and the
accompanying editorial on the “Polypill” was disappointing in focusing only
on the advantage to the population and ignoring the individual's views of ...
Cited by 3 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google